Terms: = Ovarian cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Diagnosis
16 results:
1. ECPC-IDS: A benchmark endometrial cancer PET/CT image dataset for evaluation of semantic segmentation and detection of hypermetabolic regions.
Tang D; Li C; Du T; Jiang H; Ma D; Ma Z; Grzegorzek M; Jiang T; Sun H
Comput Biol Med; 2024 Mar; 171():108217. PubMed ID: 38430743
[TBL] [Abstract] [Full Text] [Related]
2. Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study.
Yoshihara M; Mogi K; Kitami K; Uno K; Iyoshi S; Tano S; Fujimoto H; Miyamoto E; Yoshikawa N; Emoto R; Matsui S; Kajiyama H
Int J Clin Oncol; 2022 Oct; 27(10):1660-1668. PubMed ID: 35906336
[TBL] [Abstract] [Full Text] [Related]
3. Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma.
Davidson B; McFadden E; Holth A; Brunetti M; Flørenes VA
Virchows Arch; 2020 Dec; 477(6):857-864. PubMed ID: 32533344
[TBL] [Abstract] [Full Text] [Related]
4. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Vergote I; Coens C; Nankivell M; Kristensen GB; Parmar MKB; Ehlen T; Jayson GC; Johnson N; Swart AM; Verheijen R; McCluggage WG; Perren T; Panici PB; Kenter G; Casado A; Mendiola C; Stuart G; Reed NS; Kehoe S; ;
Lancet Oncol; 2018 Dec; 19(12):1680-1687. PubMed ID: 30413383
[TBL] [Abstract] [Full Text] [Related]
5. Uterine and Tubal Lavage for Earlier cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study.
Maritschnegg E; Heitz F; Pecha N; Bouda J; Trillsch F; Grimm C; Vanderstichele A; Agreiter C; Harter P; Obermayr E; Vergote I; Zeillinger R; Speiser P
Int J Gynecol Cancer; 2018 Nov; 28(9):1692-1698. PubMed ID: 30376484
[TBL] [Abstract] [Full Text] [Related]
6. Association of Mismatch Repair Mutation With Age at cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.
Ryan NAJ; Morris J; Green K; Lalloo F; Woodward ER; Hill J; Crosbie EJ; Evans DG
JAMA Oncol; 2017 Dec; 3(12):1702-1706. PubMed ID: 28772289
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic Accuracy of Serum Kallikrein-Related Peptidases for ovarian cancer: A Systematic Review and Meta-Analysis.
Lan Z; Wang F; Yu X; Zeng X; Xi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1366-74. PubMed ID: 27465901
[TBL] [Abstract] [Full Text] [Related]
8. Risk of second gonadal cancers in women and children with germ cell tumors.
Liao ZW; Rodrigues MC; Poynter JN; Amatruda JF; Rodriguez-Galindo C; Frazier AL
Cancer; 2016 Jul; 122(13):2076-82. PubMed ID: 27152727
[TBL] [Abstract] [Full Text] [Related]
9. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.
Callegaro-Filho D; Gershenson DM; Nick AM; Munsell MF; Ramirez PT; Eifel PJ; Euscher ED; Marques RM; Nicolau SM; Schmeler KM
Gynecol Oncol; 2016 Jan; 140(1):53-7. PubMed ID: 26546963
[TBL] [Abstract] [Full Text] [Related]
10. Survivors of gynecologic malignancies: impact of treatment on health and well-being.
Westin SN; Sun CC; Tung CS; Lacour RA; Meyer LA; Urbauer DL; Frumovitz MM; Lu KH; Bodurka DC
J Cancer Surviv; 2016 Apr; 10(2):261-70. PubMed ID: 26245979
[TBL] [Abstract] [Full Text] [Related]
11. Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan.
Tseng CH
Gynecol Oncol; 2013 Oct; 131(1):135-9. PubMed ID: 23877016
[TBL] [Abstract] [Full Text] [Related]
12. ovarian cancer surgery: health and coping during the perioperative period.
Seibaek L; Blaakaer J; Petersen LK; Hounsgaard L
Support Care Cancer; 2013 Feb; 21(2):575-82. PubMed ID: 22875414
[TBL] [Abstract] [Full Text] [Related]
13. Impact of body mass index on cancer development.
Yumuk PF; Dane F; Yumuk VD; Yazici D; Ege B; Bekiroglu N; Toprak A; Iyikesici S; Basaran G; Turhal NS
J BUON; 2008; 13(1):55-9. PubMed ID: 18404787
[TBL] [Abstract] [Full Text] [Related]
14. [Evolution of therapeutic practices and survival of ovarian cancer in Bourgandi between 1982-1996: a registry-based study].
Benoit L; Désir JP; Fraisse J; Arnould L; Cuisenier J
Ann Chir; 2004 Oct; 129(8):415-21. PubMed ID: 15388369
[TBL] [Abstract] [Full Text] [Related]
15. The case of the elusive androgen.
Cobin RH
Endocr Pract; 2002; 8(6):433-8. PubMed ID: 15260009
[TBL] [Abstract] [Full Text] [Related]
16. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
[TBL] [Abstract] [Full Text] [Related]
